Novartis Institutes for BioMedical Research

15 articles with Novartis Institutes for BioMedical Research

• 

  Deerfield-Backed Vicinitas Launches to Target Key Protein Stabilization

  8/1/2022

  Vicinitas launched with a Series A round worth $65 million and was co-led by a16z and Deerfield Management, with participants including Droia Ventures, GV, and the Berkeley Catalyst Fund. 
• 

  Early CAR T Patients Still in the Clear 10 Years On

  2/3/2022

  A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later.
• 

  Orna Therapeutics Circles Success With $100 Million Launch

  2/24/2021

  Orna, which began as an academic query at the Massachusetts Institute of Technology (MIT), is a biotechnology company creating fully engineered circular RNA, or O-shaped RNA therapies for the treatment of cancer, autoimmune, and genetic disorders.

• Astellas Venture Management, Pitango Venture Capital and Novartis Institutes for BioMedical Research Lead TScan Series B

  1/9/2020

  Total Series B Raise of $35 million

• SciBite Gathers 'Clean Data' Inspired Life Science Leaders at US-based Customer Meeting

  9/17/2019

  SciBite, the award-winning semantic technology company, last week hosted its annual US-based customer meeting at Novartis Institutes for BioMedical Research in Boston, MA, sparking 'clean data' discussions.

• 

  Navitor Appoints New CEO

  8/3/2018

  Navitor Pharmaceuticals, headquartered in Cambridge, Massachusetts, announced that Thomas E. Hughes will be the company’s new chief executive officer.
• 

  Novartis to Drop Anti-Infectives Research Programs and Lay Off 140

  7/12/2018

  The Novartis Institutes for BioMedical Research (NIBR) is ending its early-stage anti-infectives research programs located in Emeryville, California. As a result, the company expects to lay off about 140 employees.
• 

  Educational Institutions Highlight Biotech Through Partnerships and Programs

  5/23/2018

  Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.
• 

  Novartis Steals New Oncology Head From Pfizer

  1/11/2018

  Novartis has found its new chief of oncology.
• 

  FDA Hails Novartis' Kisqali a Breakthrough

  1/3/2018

  The company said the Breakthrough Therapy Designation is based on positive results from the Phase III MONALEESA-7 trial.
• 

  Novartis Scientist Wounded in NYC Terrorist Attack That Killed Eight People

  11/1/2017

  The scientist was among the nearly one dozen people injured on Oct. 31.

• Novartis Institutes for BioMedical Research Cambridge Campus Wins Special Recognition In Lab Of The Year Awards

  5/3/2017

• Ash Stevens Honors Cancer Research Award Winner - James E. Bradner, MD, Novartis Institutes for BioMedical Research

  4/18/2016

• Drug-Resistant Melanoma Tumors Shrink When Therapy Is Interrupted, University of California, San Francisco (UCSF), Novartis Institutes for BioMedical Research, and University Hospital Zurich Study

  1/10/2013

• Novartis Pharma AG Moves Into Old Necco Candy Factory; Sugar Will Again Be Crucial

  1/26/2004